Innova Captab
INNOVACAP · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 29, 2023

Stock Price vs Company Growth
1d
0.2%
1w
5.7%
1m
8.7%
3m
25.5%
6m
1.5%
1y
62.4%
all
34.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

777 0.2%
664
1,259
Company Overview

Sales
1,192 Cr
Growth: 14.1%
Profit after Tax
127 Cr
Growth: 7.7%
Small Cap
4,448 Cr
P/E: 34.9x
Industry P/E: 29.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,192
Growth 14.1%
EBITDA 14.8%
P/S 3.7x
Dividend 0.0%
P/E 34.9x
Book Value ₹ 162
PEG Ratio 2.5x
ROE 14.5%
P/B 4.8x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Its business includes (i) a CDMO business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business and (iii) an international branded generics business.Products of the companyTabletsCapsules Dry syrups Dry powder injection.
Followers (1)